Shinjo Yada - My portal

Profile Information

Affiliation: Graduate School of Medicine, Kyoto University

Degree: 博士（工学）(Mar, 2018, 東京理科大学)

J-GLOBAL ID: 202101016884438788
researchmap Member ID: R000016866

Research Interests

Research Areas

Life sciences / Hygiene and public health (non-laboratory) /

Awards

Sep, 2019

SASユーザー総会2019 最優秀賞
Aug, 2017

SASユーザー総会2017 奨励賞

Papers

Application of gamma process to two-agent combinations with delayed toxicity

Yada S, Hamada C

Communications in Statistics - Simulation and Computation, 50(1) 155-163, Jan, 2021 Peer-reviewedLead author
Confidence intervals for the difference between two binomial proportions derived from logistic regression

Uozumi R, Yada S, Maruo K, Kawaguchi A

Communications in Statistics - Simulation and Computation, Jan, 2020 Peer-reviewed
Patient recruitment strategies for adaptive enrichment designs with time-to-event endpoints

Uozumi R, Yada S, Kawaguchi A

BMC Medical Research Methodology, 19 159, Jul, 2019 Peer-reviewed
A Bayesian hierarchal-modeling approach to shortening phase I/II trials of anticancer drug combinations

Yada S, Hamada C

Pharmaceutical Statistics, 17(6) 750-760, Nov, 2018 Peer-reviewedLead author
Adaptive phase I/II clinical trials for drug combination assessment in oncology using the outcomes of each cycle

Yada S, Hamada C

Pharmaceutical Statistics, 16(6) 433-444, Nov, 2017 Peer-reviewedLead author
Analyses of drug combinations using missing data shortens trial periods in phase I/II oncology trials

Yada S, Hamada C

Contemporary Clinical Trials Communications, 7 73-80, Sep, 2017 Peer-reviewedLead author
Application of Bayesian hierarchical models for phase I/II clinical trials in oncology

Yada S, Hamada C

Pharmaceutical Statistics, 16(2) 114-121, Mar, 2017 Peer-reviewedLead author
代替性評価指標を利用したCRMの性能評価に関する研究

矢田真城, 浜田知久馬

臨床薬理, 45(5) 179-186, Sep, 2014 Peer-reviewedLead author
有効性と毒性を指標としたContinual Reassessment Methodの中止基準に関する研究

矢田真城, 浜田知久馬

臨床薬理, 45(1) 3-10, Jan, 2014 Peer-reviewedLead author

Misc.

Let's enjoy the computer vision using SAS Viya!

Shinjo Yada, Ryuji Uozumi

SAS Global Forum Proceedings 2021, May, 2021 Peer-reviewedLead author
がん第1相試験における2剤併用療法のInterval designの改良

太田愛作, 矢田真城, 安藤宗司, 寒水孝司

2021年度日本計量生物学会年会, 7-12, May, 2021
Estimation of direct and indirect effects by using SAS

Shinjo Yada, Ryuji Uozumi

Oct, 2020 InvitedLead author
Use of propensity score with SAS: Statistical aspects Statistical aspects of an observational study in patients with COVID-19

Ryuji Uozumi, Shinjo Yada

Oct, 2020 Invited
Introduction to statistical causal inference

Shinjo Yada, Ryuji Uozumi

Oct, 2020 InvitedLead author
ニューラルネットワークを用いたバイオマーカーに基づく治療法の選択

矢田真城, 魚住龍史

統計関連学会連合大会報告集, 276, Sep, 2020 Lead author
An adaptive design of phase I/II clinical trials for precision medicine using oncogene information

Yada S, Uozumi R

41st Annual Conference of the International Society for Clinical Biostatistics, OC13.1, Aug, 2020 Lead author
How to effectively recruit patients for adaptive enrichment clinical trials

Uozumi R, Yada S, Kawaguchi A

41st Annual Conference of the International Society for Clinical Biostatistics, Aug, 2020
反事実モデルに基づく直接効果と間接効果の推定

矢田真城, 魚住龍史, 田栗正隆

日本計量生物学, 40(2) 81-116, Jun, 2020 Peer-reviewedLead author
SASによる区間打ち切りデータを伴う生存関数の推定

魚住龍史, 中川雄貴, 矢田真城

SASユーザー総会論文集, 3-17, Sep, 2019
CAUSALGRAPHプロシジャによる因果効果の識別

矢田真城, 魚住龍史

SASユーザー総会論文集, 51-72, Sep, 2019 Lead author
CAUSALMEDプロシジャによる媒介分析

矢田真城, 魚住龍史

SASユーザー総会論文集, 29-50, Sep, 2019 Lead author
Blinded sample size re-estimation with survival data

Uozumi R, Yada S

The 6th International Symposium on Biopharmaceutical Statistics, 72, Aug, 2019
A Bayesian simulation considering late-onset outcomes for phase I/II designs of anticancer drug combinations

Yada S, Uozumi R

40th Annual Conference of the International Society for Clinical Biostatistics, Jul, 2019 Lead author
がん第1 相臨床試験におけるPIPE 法の性能評価

太田愛作, 田中優一, 矢田真城, 安藤宗司, 寒水孝司

2019年度日本計量生物学会年会, May, 2019
がん第I相試験の2 剤併用療法に対するベイズ流ノンパラメトリックアプローチ

矢田真城

2018年度統計関連学会連合大会, Sep, 2018
Use of external information for assessing efficacy equivalence in biosimilar clinical trials

Uozumi R, Yada S

統計関連学会連合大会報告集, 327, Sep, 2018
MCMCプロシジャによるコンパートメントモデルを用いた母集団薬物動態解析

矢田真城, 魚住龍史, 浜田知久馬

SASユーザー総会論文集, 37-50, Aug, 2018 Lead author
スパースな線型回帰モデルに対するベイズ推論

矢田真城, 浜田知久馬

SASユーザー総会論文集, 25-36, Aug, 2018 Lead author
SASによる時間依存性ROC曲線とC統計量

魚住龍史, 矢田真城, 篠崎智大, 川口淳, 浜田知久馬

SASユーザー総会論文集, 6-24, Aug, 2018